COLTENE Holding AG (LON:0QP7)
54.60
0.00 (0.00%)
At close: Feb 19, 2025
COLTENE Holding AG Revenue
COLTENE Holding AG had revenue of 127.50M CHF in the half year ending June 30, 2024, a decrease of -5.51%. This brings the company's revenue in the last twelve months to 238.80M, down -9.41% year-over-year. In the year 2023, COLTENE Holding AG had annual revenue of 242.73M, down -9.13%.
Revenue (ttm)
238.80M CHF
Revenue Growth
-9.41%
P/S Ratio
n/a
Revenue / Employee
191.19K CHF
Employees
1,249
Market Cap
285.90M GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 242.73M | -24.40M | -9.13% |
Dec 31, 2022 | 267.13M | -12.12M | -4.34% |
Dec 31, 2021 | 279.24M | 30.89M | 12.44% |
Dec 31, 2020 | 248.35M | -25.48M | -9.30% |
Dec 31, 2019 | 273.83M | 69.88M | 34.26% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |